Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

12_09 Cybersecurity and Data Privacy

Cybersecurity & Data Privacy for Life Sciences Companies

Cybersecurity & Data Privacy for Life Sciences Companies

Summary

Speakers

Matt Wetzel

Related Content

Washington’s My Health My Data Act Comes Into Force – What You Need to Know, and Do

A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs

In Updated Guidance on Use of Tracking Technologies by HIPAA Regulated Entities, HHS-OCR Takes Expansive View of When Information Related to Unauthenticated Individuals Is PHI

In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers

Antitrust & Competition Healthcare Year in Review 2023

FTC and DOJ Launch New Cross-Government Inquiry on the Role of Private Equity in Healthcare

SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth and Take-Home Medication Flexibilities

DOJ Renews Focus on Private Equity Amid Record False Claims Act Enforcement

Allurion Technologies Completes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Healthcare M&A and Financing Trends and Predictions for 2024 (HealthInvestor UK)

Goodwin Represents the Underwriters in PACS Group $450 Million IPO

Goodwin Guides MPT In $1.1B Hospital Sale (Law360)

Premier Technology and Life Sciences Team Joins Goodwin in Boston

The American Lawyer Names Rachael Bushey and Jennifer Porter 2024 Dealmakers of the Year

Rare Disease Drug Development: A Glimpse Into the Regulator and Investigator Perspectives (AgencyIQ)

Frazier Healthcare Partners Completes Acquisition of RevSpring

Healthcare

Medtech

Healthcare Services

Healthcare Regulatory

Healthcare Disputes & Investigations